Related Experiment Video

Updated: Aug 9, 2026

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

Anticonvulsant and antiepileptogenic effects of fluorofelbamate in experimental status epilepticus

Andrey M Mazarati1, R Duane Sofia, Claude G Wasterlain

  • 1Department of Neurology, UCLA School of Medicine, Los Angeles, CA, USA.

Seizure
|September 19, 2002
PubMed
Abstract

Insights

Fluorofelbamate demonstrates significant anticonvulsant effects against acute and chronic seizures in a status epilepticus model. This felbamate analog also shows antiepileptogenic properties, reducing epilepsy severity and inducing remission.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epilepsy Research

Background:

  • Status epilepticus (SE) is a neurological emergency characterized by prolonged seizures.
  • Developing effective treatments for both acute SE and the subsequent chronic epilepsy is crucial.
  • Felbamate analogs are being investigated for their anticonvulsant potential.

Purpose of the Study:

  • To evaluate the seizure-protective effects of fluorofelbamate, a felbamate analog.
  • To assess its efficacy in both acute and chronic seizure phases in a self-sustaining status epilepticus (SSSE) model.
  • To determine if fluorofelbamate possesses antiepileptogenic properties.

Main Methods:

  • Self-sustaining status epilepticus (SSSE) was induced in Wistar rats via perforant path stimulation.
  • Fluorofelbamate was administered intravenously at different time points after SSSE induction.
  • Seizure duration, spike profiles, and spontaneous seizure frequency were analyzed.

Main Results:

  • Fluorofelbamate dose-dependently reduced seizure duration when given early in SSSE.
  • Effective seizure attenuation was observed even when administered during late, refractory stages of SSSE.
  • Acute treatment decreased spontaneous seizure frequency and led to apparent remission of epilepsy within two months.

Conclusions:

  • Fluorofelbamate exhibits potent anticonvulsant activity in an experimental SSSE model.
  • The drug demonstrated efficacy even in late-stage SSSE, which is typically refractory to treatment.
  • Fluorofelbamate showed promising antiepileptogenic effects, reducing chronic epilepsy and inducing remission.

More Related Videos

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement06:58

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy08:26

Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy

Published on: October 19, 2021

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...